Application of sildenafil citrate/tadalafil/vardenafil in preparation of medicine for treating myopia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of sildenafil citrate and tadalafil, which is applied in drug combinations, pharmaceutical formulas, active ingredients of heterocyclic compounds, etc., can solve problems such as the lack of data and the inability to judge whether eye drops are effective in preventing myopia , to achieve the effect of reducing the axial length, delaying the development of myopia, and reducing the degree of myopia
Pending Publication Date: 2022-03-15
JINAN SANWEI MEDICAL INSTR CO LTD
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] The main active ingredient used in the above-mentioned eye drops is homatropine, but there is no corresponding data to support whether homatrop
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0027] Sildenafil citrate is applied in the preparation of myopia medicine, and specific method is as follows:
[0028] Dissolve sildenafil citrate in normal saline, keep its concentration at about 0.7 mg / mL, add eye drops auxiliary materials, mix well; then drop the above eye drops in the eyes, 1 to 3 drops each time, 1 to 4 times a day.
[0031] Tadalafil is used in the preparation of myopia medicine, and the specific method is as follows:
[0032] Dissolve sildenafil citrate in normal saline, keep the concentration at about 0.8 mg / mL, add eye drops auxiliary materials, mix well; then drop the above eye drops in the eyes, 1 to 3 drops each time, 1 to 4 times a day.
[0035] Vardenafil is used in the preparation of myopia medicine, and the specific method is as follows:
[0036] Dissolve sildenafil citrate in normal saline, keep its concentration at about 0.6 mg / mL, add eye drops auxiliary materials, mix well; then drop the above eye drops in the eyes, 1 to 3 drops each time, 1 to 4 times a day.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Property
Measurement
Unit
Diopter
aaaaa
aaaaa
Diopter
aaaaa
aaaaa
Diopter
aaaaa
aaaaa
Login to view more
Abstract
The invention belongs to the technical field of new application of medicines, and particularly relates to application of sildenafil citrate/tadalafil/vardenafil in preparation of medicines for treating myopia. The application of sildenafil citrate, tadalafil and vardenafil in preparation of the medicine for treating myopia is the key protection content of the invention, and the medicine disclosed by the invention is a liquid medicine, such as eye drops. The medicine containing sildenafil, tadalafil and vardenafil for treating shortsightedness is also the key protection content of the invention. The medicine further comprises conventional auxiliary materials contained in the eye drops, such as preservatives, excipients and the like. The medicine sildenafil citrate, tadalafil and vardenafil provided by the invention have the beneficial effects that the medicine sildenafil citrate, tadalafil and vardenafil provided by the invention are applied to the treatment of myopia medicines, so that the blood supply of retina or choroid or ciliary muscle or sclera is effectively improved; or the axial length of the inner wall of the eyeball is reduced, or the adjusting force of eyes is enhanced, so that the purpose of treating myopia is achieved.
Description
technical field [0001] The invention belongs to the technical field of new uses of medicines, and in particular relates to the application of sildenafil citrate / tadalafil / vardenafil in the preparation of medicines for treating myopia. Background technique [0002] So far, there is no ideal delay and treatment for myopia, and the degree of myopia can only be removed through invasive operations such as laser myopia surgery after adulthood. The incidence of myopia is getting higher and higher, which has become a serious social problem. Finding a non-invasive and effective method to delay myopia and even treat myopia has great social and economic significance. [0003] CN105998020A discloses an eye drop capable of preventing myopia, including homatropine, preservative, pH regulator, isotonic regulator and diluent, and the ratio of each component is: homatropine: 0.01%-0.3% ; Preservative: 0.001%-0.05%; pH regulator: adjust the pH value to 6.6-7.2; Isotonic regulator 1%-10%; Dil...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more